Back to News
Market Impact: 0.2
West Pharmaceutical Services Consensus Price Target Raised 12.52% to $467.89
Source: Nasdaq
Analyst InsightsAnalyst Estimates
The average one-year price target for West Pharmaceutical Services was revised up 12.52% to $467.89 per share from $415.83, the prior estimate dated October 20, 2026. The figures are an aggregate of analyst targets; no share-price reaction or further details are provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
WST0.35
More News
- Jefferies raises West Pharmaceutical stock price target on HVP growth
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Reliance’s Record $19 Billion Surge Lifts Nifty, Keeps India Bulls in the Game
- Apple reports after the bell. Options traders expect a big move
- Mizuho lowers Lumentum stock price target on Marvell acquisition
- Why is Apple stock falling afterhours today?